Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q1 2023 · 10-Q
Revenue$7.82M$7.82M+7.8% vs Q1 2022 Net Income$766.81K$766.81K−7.8% vs Q1 2022 EPS Diluted$0.09$0.09−10.0% vs Q1 2022 Operating Income$1,683,171+14.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Free Cash Flowderived$1,268,326+47.6% Margins · derivedOperating margin21.5%+1.3 pt vs Q1 2022
Net margin9.8%−1.7 pt vs Q1 2022
ended Feb 28, 2023 · filed Apr 21, 2023 · 52 d after period end